Asia-pacific Cardiovascular Ultrasound Market Forecast 2022-2030

The Asia-Pacific cardiovascular ultrasound market is set to record a CAGR of 6.61% during the forecast period, 2022-2030. The huge demand for portable ultrasound in the region is due to the rising preference for minimally invasive surgeries. Also, the market is expanding in countries like China, with the entry of new companies. However, the market growth is restrained by the scarcity of echocardiography experts, particularly for focused cardiac ultrasound (FOCUS).

MARKET INSIGHTS

Singapore, Taiwan, Indonesia, China, Japan, India, South Korea, Australia & New Zealand, and Rest of Asia-Pacific are assessed for the Asia-Pacific cardiovascular ultrasound market growth analysis. In Japan, the surging number of heart failure patients is a major health concern. Accordingly, several companies are focusing on incorporating advanced technology into ultrasound machines. The key players in Japan include FUJIFILM Holdings Corporation and Canon Medical. Canon Medical offers an extensive range of diagnostic medical imaging solutions like healthcare informatics, ultrasound, x-ray, MR, and CT.

In India, cardiovascular diseases (CVDs) are among the non-communicable diseases that account for 60% of total deaths. CVDs have become the leading cause of death in the country. The most common evaluated causes are stroke and ischemic heart disease, contributing to over 80% of cardiovascular disease deaths. Additionally, certain of CVDs are concerning, for instance, its fast-paced spread, the young age population increasingly becoming vulnerable to the disease, and the high fatality rates. Accordingly, prominent players like Siemens Healthineers and Philips Healthcare are offering cardiovascular ultrasound machines to sustain the needs of the healthcare sector and help timely detection and treatment of CVDs.

COMPETITIVE INSIGHTS

Lanmage, Leltek, Philips Healthcare, Mindray Medical International Limited, etc., are among the key firms in the market.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 16317

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING CARDIOVASCULAR DISEASES
- 3.1.2. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
- 3.2.1. LACK OF AWARENESS AMONG PATIENTS
- 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON CARDIOVASCULAR ULTRASOUND MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. QUALITY
- 4.7.2. DURABILITY
- 4.7.3. PRICE
- 4.7.4. TECHNOLOGY

5. MARKET BY DISPLAY

5.1. BLACK AND WHITE
5.2. COLOR

6. MARKET BY TECHNOLOGY

6.1. 2D
6.2. 3D/4D
6.3. DOPPLER

7. MARKET BY TYPE

7.1. TRANSTHORACIC ECHOCARDIOGRAPHY
7.2. FETAL ECHOCARDIOGRAPHY
7.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
7.4. OTHER TYPES

8. MARKET BY END-USER

8.1. HOSPITALS
8.2. DIAGNOSTIC CENTERS
8.3. AMBULATORY CARE CENTERS
8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

9.1. ASIA-PACIFIC
- 9.1.1. MARKET SIZE & ESTIMATES
- 9.1.2. KEY GROWTH ENABLERS
- 9.1.3. KEY CHALLENGES
- 9.1.4. KEY PLAYERS
- 9.1.5. COUNTRY ANALYSIS
  - 9.1.5.1. CHINA
  - 9.1.5.2. JAPAN
  - 9.1.5.3. INDIA
  - 9.1.5.4. SOUTH KOREA
  - 9.1.5.5. INDONESIA
  - 9.1.5.6. SINGAPORE
  - 9.1.5.7. TAIWAN
  - 9.1.5.8. AUSTRALIA & NEW ZEALAND
  - 9.1.5.9. REST OF ASIA-PACIFIC

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.2. PARTNERSHIPS & AGREEMENTS
10.2. COMPANY PROFILES
- 10.2.1. CANON MEDICAL SYSTEMS CORPORATION
- 10.2.2. CLARIUS
- 10.2.3. DAWEI MEDICAL
- 10.2.4. ESAOTE SPA
- 10.2.5. FUJIFILM HOLDINGS CORPORATION
- 10.2.6. GE HEALTHCARE
- 10.2.7. LANMAGE
- 10.2.8. LELTEK
- 10.2.9. MINDRAY MEDICAL INTERNATIONAL LIMITED
- 10.2.10. PHILIPS HEALTHCARE
- 10.2.11. SAMSUNG MEDISON CO LTD
- 10.2.12. SIEMENS HEALTHINEERS
- 10.2.13. TELEMED ULTRASOUND MEDICAL SYSTEMS
- 10.2.14. VIATOM TECHNOLOGY CO
- 10.2.15. ZONCARE